MedPath

A joint MRC/European Organisation for Research and Treatment of Cancer (EORTC) study of radiotherapy for low grade astrocytomas and oligodendrogliomas

Completed
Conditions
Cancer
Astrocytomas and oligodendrogliomas
Registration Number
ISRCTN17931175
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
250
Inclusion Criteria

1. Age 16-66
2. World Health Organisation (WHO) performance status 0-2
3. Neurosurgery within past 8 weeks
4. No previous malignancy
5. No previous treatment except surgery
6. Corticosteroids, anticonvulsants or diuretics
7. No condition likely to prejudice treatment or follow up

Exclusion Criteria

History of cardiac disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath